|
Congestive Heart Failure/ Cardiomyopathy
Citations 71-80 of 177 total displayed.
|
Past content
(since Feb 1998):
|
- Letters
Performance Measures and Outcomes for Patients Hospitalized With Heart Failure
- Martha J. Radford; Robert O. Bonow; Raymond J. Gibbons; Steven E. Nissen
JAMA 2007; 297: 1547-a-1548-a.
[Extract]
[Full text]
[PDF]
- Letters
Performance Measures and Outcomes for Patients Hospitalized With Heart Failure
- Mehdi H. Shishehbor; David Litaker
JAMA 2007; 297: 1547.
[Extract]
[Full text]
[PDF]
- Letters
Performance Measures and Outcomes for Patients Hospitalized With Heart FailureReply
- Gregg C. Fonarow; Clyde W. Yancy; William T. Abraham; Barry H. Greenberg
JAMA 2007; 297: 1548-1549.
[Extract]
[Full text]
[PDF]
- Original Contributions
Effects of Oral Tolvaptan in Patients Hospitalized for Worsening Heart Failure: The EVEREST Outcome Trial
- Marvin A. Konstam; Mihai Gheorghiade; John C. Burnett Jr; Liliana Grinfeld; Aldo P. Maggioni; Karl Swedberg; James E. Udelson; Faiez Zannad; Thomas Cook; John Ouyang; Christopher Zimmer; Cesare Orlandi; for the Efficacy of Vasopressin Antagonism in Heart Failure Outcome Study With Tolvaptan (EVEREST) Investigators
JAMA 2007; 297: 1319-1331.
[Abstract]
[Full text]
[PDF]
[ JAMA News Video ]
- Original Contributions
Short-term Clinical Effects of Tolvaptan, an Oral Vasopressin Antagonist, in Patients Hospitalized for Heart Failure: The EVEREST Clinical Status Trials
- Mihai Gheorghiade; Marvin A. Konstam; John C. Burnett Jr; Liliana Grinfeld; Aldo P. Maggioni; Karl Swedberg; James E. Udelson; Faiez Zannad; Thomas Cook; John Ouyang; Christopher Zimmer; Cesare Orlandi; for the Efficacy of Vasopressin Antagonism in Heart Failure Outcome Study With Tolvaptan (EVEREST) Investigators
JAMA 2007; 297: 1332-1343.
[Abstract]
[Full text]
[PDF]
- Editorials
Climbing the Mountain of Acute Decompensated Heart Failure: The EVEREST Trials
- Clyde W. Yancy
JAMA 2007; 297: 1374-1376.
[Extract]
[Full text]
[PDF]
- Letters
Statin Use and Risks for Death and Hospitalization in Chronic Heart Failure
- Wayne Gerard; Julia Gerard
JAMA 2007; 297: 1057-a-1058-a.
[Extract]
[Full text]
[PDF]
- Letters
Statin Use and Risks for Death and Hospitalization in Chronic Heart Failure
- Samy Suissa
JAMA 2007; 297: 1057.
[Extract]
[Full text]
[PDF]
- Letters
Classifying Systolic and Diastolic Heart Failure
- Viorel G. Florea
JAMA 2007; 297: 1058-a-1059-a.
[Extract]
[Full text]
[PDF]
- Letters
Statin Use and Risks for Death and Hospitalization in Chronic Heart FailureReply
- Alan S. Go; Jingrong Yang; Jerry H. Gurwitz
JAMA 2007; 297: 1058.
[Extract]
[Full text]
[PDF]
|
|